Tata Elxsi Limited (TATAELXSI) — Announcement | 27 July 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Tata Elxsi partners with SCTIMST for healthcare innovation

Tata Elxsi announced a strategic partnership with SCTIMST to co-develop healthcare technologies, combining clinical research with engineering capabilities to accelerate medical device innovation for Indian and global markets, as stated in the July 27, 2026 press release.

📄 View Original Announcement (PDF)

About Tata Elxsi Limited (TATAELXSI)

Information Technology · IT - Software · Listed on NSE

Market Cap: ₹22,333.5 Cr P/E: 109.4 ROE: 36.0% ROCE: 54.7% Div Yield: 0.31%

View full TATAELXSI stock details →

📡 Get AI alerts when TATAELXSI files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TATAELXSI — Free

📊 More TATAELXSI filings

See all TATAELXSI filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TATAELXSI files new disclosures

Track TATAELXSI filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track TATAELXSI — Free

Free account · 2 AI queries/day